Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study

Michael Liu, Brian MacKenna, William B Feldman, Alex J Walker, Jerry Avorn, Aaron S Kesselheim & Ben Goldacre
SummaryObjectivesTo estimate additional spending if NHS England paid the same prices as US Medicare Part D for the 50 single-source brand-name drugs with the highest expenditure in English primary care in 2018.DesignRetrospective analysis of 2018 drug prescribing and spending in the NHS England prescribing data and the Medicare Part D Drug Spending Dashboard and Data. We examined the 50 costliest drugs in English primary care available as brand-name-only in the US and England. We performed...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.